Literature DB >> 34092231

Biopsy in emergency gastroscopy does not increase the risk of rebleeding in patients with Forrest I acute nonvariceal upper gastrointestinal bleeding combined with suspected malignant gastric ulcer: a multicenter retrospective cohort study.

Quchuan Zhao1, Tianyu Chi2.   

Abstract

BACKGROUND: Few studies have reported whether a biopsy in emergency gastroscopy (EG) increased the risk of rebleeding in patients with Forrest I acute nonvariceal upper gastrointestinal bleeding (ANVUGIB) combined with suspected malignant gastric ulcer (SMGU). This study aims to conduct a multicenter retrospective cohort study using propensity score matching to verify whether a biopsy in EG increases the risk of rebleeding in patients diagnosed with Forrest I ANVUGIB combined with SMGU.
METHODS: Using the data for propensity-matched patients, logistic regression models were fitted using rebleeding as the dependent variable. Survival time was defined as the length of time the patient experienced from visiting the emergency department to rebleeding. We used the Kaplan-Meier (KM) method to analyze the 30-day survival of the patients with and without a biopsy after matching, and the log-rank test was performed to examine the differences in survival.
RESULTS: With the use of propensity score matching, 308 patients who underwent a biopsy in EG were matched with 308 patients who did not. In the five logistic regression models, there were no significant group differences in the risk of rebleeding in patients with Forrest I ANVUGIB combined with SMGU between the biopsy and no-biopsy groups. The probability of survival was not significantly different between the no-biopsy and biopsy groups.
CONCLUSIONS: In this multicenter, retrospective propensity score matching cohort study, compared with patients without a biopsy, patients with a biopsy during EG had no increased risk of rebleeding, and there was no significant difference in the rate of rebleeding.

Entities:  

Keywords:  Antithrombotic; Biopsy; Endoscopy; Nonvariceal upper gastrointestinal bleeding; Rebleeding

Mesh:

Year:  2021        PMID: 34092231     DOI: 10.1186/s12876-021-01836-z

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  17 in total

Review 1.  Management of patients with ulcer bleeding.

Authors:  Loren Laine; Dennis M Jensen
Journal:  Am J Gastroenterol       Date:  2012-02-07       Impact factor: 10.864

Review 2.  Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding.

Authors:  Thomas Tielleman; Daniel Bujanda; Byron Cryer
Journal:  Gastrointest Endosc Clin N Am       Date:  2015-07

3.  Urgent endoscopy is associated with lower mortality in high-risk but not low-risk nonvariceal upper gastrointestinal bleeding.

Authors:  L G Lim; K Y Ho; Y H Chan; P L Teoh; C J Khor; L L Lim; A Rajnakova; T Z Ong; K G Yeoh
Journal:  Endoscopy       Date:  2011-02-28       Impact factor: 10.093

4.  Aspirin Has a Protective Effect Against Adverse Outcomes in Patients with Nonvariceal Upper Gastrointestinal Bleeding.

Authors:  Antonios Wehbeh; Hani M Tamim; Hussein Abu Daya; Rachel Abou Mrad; Rami J Badreddine; Mohamad A Eloubeidi; Don C Rockey; Kassem Barada
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

5.  Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study.

Authors:  V Jairath; B C Kahan; R F A Logan; S A Hearnshaw; C J Doré; S P L Travis; M F Murphy; K R Palmer
Journal:  Endoscopy       Date:  2012-07-02       Impact factor: 10.093

6.  International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

7.  Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

Authors:  Ian M Gralnek; Jean-Marc Dumonceau; Ernst J Kuipers; Angel Lanas; David S Sanders; Matthew Kurien; Gianluca Rotondano; Tomas Hucl; Mario Dinis-Ribeiro; Riccardo Marmo; Istvan Racz; Alberto Arezzo; Ralf-Thorsten Hoffmann; Gilles Lesur; Roberto de Franchis; Lars Aabakken; Andrew Veitch; Franco Radaelli; Paulo Salgueiro; Ricardo Cardoso; Luís Maia; Angelo Zullo; Livio Cipolletta; Cesare Hassan
Journal:  Endoscopy       Date:  2015-09-29       Impact factor: 10.093

Review 8.  Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents.

Authors:  Angelo Zullo; Cesare Hassan; Franco Radaelli
Journal:  Ann Gastroenterol       Date:  2016-10-07

9.  Clinical Practice and Guidelines for Managing Antithrombotics before and after Endoscopy: A National Survey Study.

Authors:  Seong Woo Jeon; Su Jin Hong; Soo Teik Lee; Hyungkil Kim; Hoon Jai Chun
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

10.  Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group.

Authors:  Alan N Barkun; Majid Almadi; Ernst J Kuipers; Loren Laine; Joseph Sung; Frances Tse; Grigorios I Leontiadis; Neena S Abraham; Xavier Calvet; Francis K L Chan; James Douketis; Robert Enns; Ian M Gralnek; Vipul Jairath; Dennis Jensen; James Lau; Gregory Y H Lip; Romaric Loffroy; Fauze Maluf-Filho; Andrew C Meltzer; Nageshwar Reddy; John R Saltzman; John K Marshall; Marc Bardou
Journal:  Ann Intern Med       Date:  2019-10-22       Impact factor: 25.391

View more
  1 in total

1.  Deep learning as a novel method for endoscopic diagnosis of chronic atrophic gastritis: a prospective nested case-control study.

Authors:  Quchuan Zhao; Qing Jia; Tianyu Chi
Journal:  BMC Gastroenterol       Date:  2022-07-25       Impact factor: 2.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.